Success stories from The Division of Global HIV & TB
When Nokwazi Ndlovu* from Umlazi Township, south of Durban in KwaZulu-Natal, South Africa was sexually assaulted by her stepfather she told her mother, but her mother didn’t believe her. Instead, she allegedly defended him saying he would never commit such a heinous act.
More than a decade ago, the U.S. Government launched the President’s Emergency Plan for AIDS Relief (PEPFAR) to help bring lifesaving treatment to as many people as possible in sub-Saharan Africa – the epicenter of the world’s AIDS crisis. But as treatment efforts expanded, it became increasingly clear that weak laboratory systems were undermining efforts to effectively fight the disease across the continent.
Deep in the mines of South Africa, men and women are hard at work extracting the precious minerals that place the country near the top of the list of the world’s biggest exporters; however, the job does not come without risks. Miners regularly find themselves facing dangerous situations that put them at risk of injury and/or illness. One of these risks is tuberculosis (TB).
Eva, the second of seven children, lost her dad at age 12. Unable to afford to finish school, Eva accepted a job as a domestic worker for a woman in her village in central Uganda. She never could have known, however, that the job was in fact something quite different.
A new CDC study examining the first decade of HIV antiretroviral therapy (ART) scale-up in Mozambique revealed fewer people are dying from HIV in recent years, likely due to more patients starting treatment at earlier disease stages. The analysis also found that people who more recently began ART were less likely to remain engaged in HIV treatment and care over time.
Over the years, TB has begun to outwit the drugs used to combat it in the body, leading to drug-resistant forms of the disease. These forms of TB are resistant to our best and most potent drugs, threatening decades of progress against the disease. Drug resistant TB is more difficult to diagnose, is longer and costlier to treat, can cause serious, permanent side effects, and significantly increases the risk of death.
In Chitungwiza district, just outside Zimbabwe’s capital of Harare, a growing crowd gather to watch a group of street performers. While the group sways together to the captivating reggae beat – community mobilizers quietly move throughout the crowd distributing information about voluntary medical male circumcision (VMMC) to men and boys.
When you meet Marlyne, you can sense that she has a strength and determination that belies her tender age. Like many 13-year-old girls in Kenya, she dreams of a better life for herself and her family, and she is willing to work hard to achieve her goals.